Endocrinologists often see diabetic ketoacidosis or ketosis as a hallmark of type 1 diabetes in skinny young patients, but this study reveals that one-fourth of adult Caucasian patients presenting with new-onset ketosis actually have ketosis-prone type 2 diabetes, a form that defies classic classifications and maintains insulin production for years despite the dramatic presentation. 
In the study published in the Diabetes & Metabolic Syndrome: Clinical Research & Reviews, the researchers retrospectively analyzed electronic medical records from 183 newly diagnosed patients, finding 86 with ketosis at diagnosis, and carefully classified them into type 1, latent autoimmune diabetes of adults, ketosis-prone type 2, or non-ketotic type 2 diabetes based on ketosis status, absence of diabetes autoantibodies, and fasting C-peptide levels within the normal reference range for the ketosis-prone group. 
Classic Misdiagnosis Traps Unwary Clinicians
Many physicians immediately start lifelong insulin for any adult arriving in ketoacidosis, missing that ketosis-prone type 2 accounts for one-fourth of ketotic presentations in this cohort and behaves more like metabolic type 2 diabetes after the acute phase resolves.
Striking Baseline Differences Emerge
Ketosis-prone type 2 patients differed sharply from type 1 diabetes cases by being older with mean age of 54.9 years versus 34.8 years (P<0.0001), more obese at BMI 31.5 kg/m² versus 22.5 kg/m² (P<0.0001), having higher HbA1c levels at 13.3% versus 10.8% (P=0.0047), and showing much greater hepatic steatosis through hepatic steatosis index scores of 45.4 versus 34.7 (P<0.0001). These characteristics paint a picture of middle-aged patients with classic type 2 risk factors who decompensate into ketosis under extreme glucotoxicity.
Beta-Cell Resilience Spans Decades
What truly sets this group apart lies in their sustained insulin secretion, with fasting C-peptide holding steady at 4.37 ng/mL after 5-10 years and still measuring 2.85 ng/mL after 10-15 years post-index episode, allowing many to thrive on oral agents rather than permanent insulin injections.
Emergency Room Triage Needs Overhaul
Overweight middle-aged patients landing in DKA may require immediate autoantibody panel and C-peptide measurement alongside standard resuscitation, as ketosis-prone type 2 diagnosis shifts management from insulin dependence to beta-cell preservation strategies post-recovery.
Fatty Liver Links Demand Attention
Elevated hepatic steatosis index underscores metabolic syndrome's central role in ketosis-prone type 2 pathogenesis, prompting liver ultrasound and lifestyle interventions alongside glycemic control to prevent long-term complications.
Long-Term Follow-Up Proves Favorable
Preserved C-peptide over 15 years confirms excellent prognosis for ketosis-prone type 2 patients who avoid misclassification, supporting annual monitoring rather than aggressive escalation.
Practice-Changing Testing Protocols
Endocrinologists should standardize C-peptide and GAD/IA-2 testing in all adult ketosis cases regardless of race, expanding ketosis-prone type 2 recognition beyond traditional populations and optimizing therapy for sustained remission.